|
July 03, 2026 — FxNutrition Intelligence
Evidence-driven intelligence for functional nutrition practitioners
A Nutrishify publication • Week of July 03, 2026
|
|
Metabolic health doesn’t stay in its lane — what happens at the breakfast table can ripple all the way to the brain. This week’s research spans three high-stakes arenas: eating window timing and hormonal health, the growing evidence linking insulin resistance to dementia risk, and a surprising new use for a familiar omega-3 compound in stroke recovery.
This week’s issue lands just ahead of a big one — the country’s 250th birthday. However you’re celebrating, we hope it’s a good one!
|
|
Evidence Spotlight
|
Insulin Resistance & Dementia Risk
A meta-analysis of 10 prospective cohort studies found insulin resistance is linked to a 23% higher risk of Alzheimer’s disease and an 11% higher risk of all-cause dementia. The association held across multiple dementia subtypes; because these are observational studies, causal direction is not confirmed.
Takeaway: For practitioners already addressing insulin resistance, this adds prospective evidence that reducing it may also lower long-term dementia risk.
|
EPA in Stroke Recovery
A 12-week randomized controlled trial (n=80 adults with acute ischemic stroke) found that adding icosapent ethyl, a prescription-only purified EPA compound containing no DHA, at 2,000 mg/day to standard treatment significantly improved functional recovery compared to placebo. The EPA group also showed greater reductions in interleukin-6, though C-reactive protein did not differ significantly.
Takeaway: Icosapent ethyl (Vascepa) is a prescription pure-EPA product, not standard fish oil. FDA-approved for high triglycerides, this trial suggests its anti-inflammatory properties may also support functional recovery after ischemic stroke.
Read study → Annals of Clinical and Translational Neurology, July 01, 2026
|
TRE Timing & PCOS
A 6-week randomized controlled trial (n=75 women with polycystic ovary syndrome) compared two eating windows to unrestricted eating: an early window (8 AM–6 PM) and a midday window (11 AM–9 PM). Both reduced fasting insulin, blood sugar, and body weight. Only the early window also improved cholesterol levels.
Takeaway: For PCOS clients using time-restricted eating (TRE), when the window is placed may matter as much as how long it runs. An earlier schedule produced cholesterol improvements that the midday window did not.
|
BY THE NUMBERS
23%
Insulin resistance is linked to a 23% higher risk of developing Alzheimer’s disease.
A meta-analysis of 10 prospective cohort studies found that insulin resistance is associated with a 23% increased risk of Alzheimer’s disease (HR = 1.23, 95% CI 1.01–1.50) and an 11% increased risk of all-cause dementia (HR = 1.11). The finding spans multiple dementia subtypes and positions insulin management as a potentially modifiable lever for long-term brain health.
BMC Neurology — Xu et al., 2026
|
CLINICAL PEARL
EPA Supports Stroke Recovery Beyond Standard Care
A 12-week randomized controlled trial found that adding icosapent ethyl, a prescription-only purified EPA formulation with no DHA, at 2,000 mg/day to standard stroke treatment significantly improved functional recovery compared to placebo. The EPA group showed greater reductions on two functional recovery scales alongside a significant decrease in interleukin-6. C-reactive protein did not change significantly.
Annals of Clinical and Translational Neurology
|
|
|
Recent Podcasts
|
Essentials: Tools for Hormone Optimization in Males | Dr. Kyle Gillett
Huberman Lab • July 02, 2026
Dr. Kyle Gillett joins Andrew Huberman on Huberman Lab for a focused episode on male hormone optimization, covering nutrition, supplementation, and testosterone support across the lifespan. The standout section offers specific dosing context for supplements like creatine, L-carnitine, and Tongkat Ali. Practical for practitioners fielding male hormonal health questions. Listen →
|
5 Foods to Lose Fat, Regulate Your Appetite and Improve Your Metabolism Without Counting Calories
The Doctor’s Kitchen • July 01, 2026
Dr. Federica Amati joins Dr. Rupy Aujla on The Doctor’s Kitchen to discuss five evidence-based foods for fat loss, appetite regulation, and metabolism without calorie counting. The most clinically relevant section covers GLP-1 nutritional support strategies and how to optimize nutrition before, during, and after GLP-1 medications. Practical for practitioners guiding clients through metabolic health or GLP-1 adjunct nutrition. Listen →
|
Choosing the Right Progesterone Prescription: A Discussion on OMP & Vaginal Progesterone
DUTCH Podcast • June 30, 2026
Dr. Felice Gersh joins the DUTCH Podcast to challenge standard progesterone prescribing, with a focus on concerns about oral micronized progesterone and the case for vaginal alternatives. The key clinical question examined: whether standard oral dosing produces more of the sedating metabolite allopregnanolone than most practitioners realize. Worth listening for anyone managing hormone therapy in female patients. Listen →
|
Gut, Brain, and Hormones: The Menopause Connection
unPAUSED • June 30, 2026
Dr. Amy Shah joins Dr. Mary Claire Haver on unPAUSED to explore the gut-hormone-brain connection in perimenopausal women. The core clinical insight: declining estrogen loosens gut tight junctions, driving systemic inflammation, and since 95% of serotonin is gut-produced, dysbiosis directly fuels mood, sleep, and metabolic symptoms. Worth listening for practitioners working with perimenopausal clients who present with overlapping hormonal and digestive complaints. Listen →
|
Integrative and Functional Nutrition Dietitians: How They Amplify Care
The Root Cause Medicine Podcast • June 26, 2026
Dr. Kate Kresge hosts three integrative nutrition dietitians on The Root Cause Medicine Podcast to explore how they extend what functional medicine appointments can accomplish. The core argument: sustained behavior change requires more time and contextual support than any single medical visit provides. Relevant for practitioners considering how dietitian referrals fit into their model. Listen →
|
|
Mark Your Calendar
|
July 15
Why Your Practice Isn’t Growing (Even If You’re a Great Doctor)
Diagnostic Solutions Laboratory · Free Live Webinar — Register →
|
August 01
Transforming Gut Health with GI Effects® — A Comprehensive Clinician Course
Genova Diagnostics · Free Virtual Course — Register →
|
August 05
The Hormone-Mitochondria Axis: Linking Endocrinology to Cellular Bioenergetics
Doctor’s Data · Presented by Laura Neville, ND | August 5, 2026 at 12 PM Pacific — Register →
|
|
Tech Tip
|
Why Your Clients Still Need You in the Age of AI
Think your tech-savvy clients are getting better nutrition advice from AI than they’d get from you? Research suggests the opposite.
Wharton professor Ethan Mollick, whose team conducted a landmark AI study with Boston Consulting Group, found that experienced professionals consistently outperform novices when using AI — because they know when it’s wrong. Your clients using ChatGPT to interpret their labs or design an elimination diet have no way to spot a flawed output, catch a dangerous oversimplification, or know what question to ask next. You do.
That clinical judgment — built through training, supervised practice, and real patient outcomes — is exactly what AI can’t replicate. It’s not just your value proposition. It’s the thing standing between your client and confidently wrong advice.
|
|
© 2026 Nutrishify · Questions or feedback? Email hello@nutrishify.com
|
